Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Non-cash Items: 2015-2024

Historic Non-cash Items for Adma Biologics (ADMA) over the last 8 years, with Dec 2024 value amounting to $68.1 million.

  • Adma Biologics' Non-cash Items rose 9.91% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 9.91%. This contributed to the annual value of $68.1 million for FY2024, which is 664.16% up from last year.
  • As of FY2024, Adma Biologics' Non-cash Items stood at $68.1 million, which was up 664.16% from $8.9 million recorded in FY2023.
  • Adma Biologics' Non-cash Items' 5-year high stood at $68.1 million during FY2024, with a 5-year trough of $35,935 in FY2021.
  • Its 3-year average for Non-cash Items is $28.2 million, with a median of $8.9 million in 2023.
  • Data for Adma Biologics' Non-cash Items shows a peak YoY surged of 21,161.28% (in 2022) over the last 5 years.
  • Adma Biologics' Non-cash Items (Yearly) stood at $35,935 in 2021, then spiked by 21,161.28% to $7.6 million in 2022, then increased by 16.67% to $8.9 million in 2023, then spiked by 664.16% to $68.1 million in 2024.